{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:56:42Z","timestamp":1792699002349,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["1R01EB034369-01A1"],"award-info":[{"award-number":["1R01EB034369-01A1"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","academicradiology.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.acra.2024.02.027","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T13:24:36Z","timestamp":1710163476000},"page":"1836-1838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Yttrium-90 Transarterial Radioembolization: An Effective Primary or Salvage Therapy to Bridge the Patients with Hepatocellular Carcinoma to Liver Transplantation"],"prefix":"10.1016","volume":"31","author":[{"given":"Xudong","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5559-8562","authenticated-orcid":false,"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.acra.2024.02.027_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.acra.2024.02.027_bib2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1007\/s00261-018-1802-y","article-title":"Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma","volume":"44","author":"Kirchner","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.acra.2024.02.027_bib3","article-title":"Long-term clinical outcomes of Yttrium-90 transarterial radioembolization for hepatocellular carcinoma: a 5-year institutional experience","author":"Makary","year":"2023","journal-title":"Acad Radiol"},{"issue":"5","key":"10.1016\/j.acra.2024.02.027_bib4","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00330-016-4548-3","article-title":"Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus (90)Y-radioembolization for hepatocellular carcinoma","volume":"27","author":"Ludwig","year":"2017","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.acra.2024.02.027_bib5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s11605-022-05559-8","article-title":"Yttrium-90 radioembolization: current indications and outcomes","volume":"27","author":"Hamad","year":"2023","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.acra.2024.02.027_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study Of The L","year":"2012","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.acra.2024.02.027_bib7","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1007\/s00330-023-09390-w","article-title":"Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT\/CT anatomical and volumetric results during the planification of radioembolization for HCC","volume":"33","author":"Derbel","year":"2023","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1016\/j.acra.2024.02.027_bib8","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00270-022-03215-x","article-title":"Trans-arterial radioembolization dosimetry in 2022","volume":"45","author":"Garin","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"10.1016\/j.acra.2024.02.027_bib9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"issue":"25","key":"10.1016\/j.acra.2024.02.027_bib10","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1200\/JCO.2010.28.7805","article-title":"Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting","volume":"28","author":"Thomas","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.acra.2024.02.027_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.acra.2024.02.027_bib12","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jvir.2013.07.026","article-title":"Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience","volume":"24","author":"Tohme","year":"2013","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"10.1016\/j.acra.2024.02.027_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1148\/radiol.211806","article-title":"(90)Y Radioembolization versus drug-eluting bead chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE phase II randomized controlled trial","volume":"303","author":"Dhondt","year":"2022","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.acra.2024.02.027_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224000989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224000989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T02:12:29Z","timestamp":1715134349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633224000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1076633224000989"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2024.02.027","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yttrium-90 Transarterial Radioembolization: An Effective Primary or Salvage Therapy to Bridge the Patients with Hepatocellular Carcinoma to Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2024.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}